GB8316516D0 - Derivatives of pyridazinones - Google Patents

Derivatives of pyridazinones

Info

Publication number
GB8316516D0
GB8316516D0 GB838316516A GB8316516A GB8316516D0 GB 8316516 D0 GB8316516 D0 GB 8316516D0 GB 838316516 A GB838316516 A GB 838316516A GB 8316516 A GB8316516 A GB 8316516A GB 8316516 D0 GB8316516 D0 GB 8316516D0
Authority
GB
United Kingdom
Prior art keywords
pyridazinones
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB838316516A
Other versions
GB2122195A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thea Therapeutique & Applicat
Original Assignee
Thea Therapeutique & Applicat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Therapeutique & Applicat filed Critical Thea Therapeutique & Applicat
Publication of GB8316516D0 publication Critical patent/GB8316516D0/en
Publication of GB2122195A publication Critical patent/GB2122195A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB08316516A 1982-06-18 1983-06-17 Pyridazinones Withdrawn GB2122195A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (en) 1982-06-18 1982-06-18 ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE

Publications (2)

Publication Number Publication Date
GB8316516D0 true GB8316516D0 (en) 1983-07-20
GB2122195A GB2122195A (en) 1984-01-11

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08316516A Withdrawn GB2122195A (en) 1982-06-18 1983-06-17 Pyridazinones

Country Status (10)

Country Link
JP (1) JPS5910571A (en)
KR (1) KR860001339B1 (en)
BE (1) BE897085A (en)
CH (1) CH657125B (en)
DE (1) DE3321772A1 (en)
FR (1) FR2528837A1 (en)
GB (1) GB2122195A (en)
GR (1) GR78284B (en)
IT (1) IT1194281B (en)
NL (1) NL8302087A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (en) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenyl pyridazinones
JPS63220512A (en) * 1987-03-09 1988-09-13 松下電器産業株式会社 Electrode foil for electrolytic capacitor
JPH04100106U (en) * 1991-02-12 1992-08-28
JPH0776050B2 (en) * 1991-07-25 1995-08-16 実 近藤 Work transfer device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (en) * 1973-02-01 1974-08-08 Basf Ag 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines

Also Published As

Publication number Publication date
FR2528837A1 (en) 1983-12-23
KR840005105A (en) 1984-11-03
JPS5910571A (en) 1984-01-20
CH657125B (en) 1986-08-15
FR2528837B1 (en) 1984-12-07
DE3321772A1 (en) 1983-12-22
IT8321684A0 (en) 1983-06-17
NL8302087A (en) 1984-01-16
BE897085A (en) 1983-12-19
GB2122195A (en) 1984-01-11
IT1194281B (en) 1988-09-14
KR860001339B1 (en) 1986-09-15
GR78284B (en) 1984-09-26

Similar Documents

Publication Publication Date Title
GB8408815D0 (en) Derivatives of azet-2-ones
GB8303882D0 (en) Use of quinoline derivatives
GB8300400D0 (en) 5-methylthiopyrimidine derivatives
GB2128188B (en) Propynylaminoisoxazole derivatives
EP0096296A3 (en) 1-sulfo-2-oxoazetidine derivatives
EP0100250A3 (en) Methylflavone derivatives
GB2132617B (en) Propynlaminothiazole derivatives
GB2129426B (en) Compounds of thiatriazines
GB8316516D0 (en) Derivatives of pyridazinones
GB2123815B (en) Aletheine derivatives
GB2131803B (en) Oxacephalosporin derivatives
IL69322A0 (en) Preparation of substituted thiadiazolylacetamides
DE3360020D1 (en) Fungicide-active derivatives of benzhydrole
GB8310144D0 (en) Substituted derivatives of thia-morpholinone
GB2121786B (en) 23-demycinosyldesmycosin derivatives
GB2116170B (en) 23-0-acyl-23-demycinosyldesmycosin derivatives
ZA827270B (en) Thiosulfenamide derivatives of n-phosphonomethylglycinonitriles
GB8300977D0 (en) Preparation of substituted chloroacentanilides
AU563533B2 (en) Pyridazinone derivatives
ZA832380B (en) Sanitere en/of onmatige voering
DE3372207D1 (en) Amino-polyol derivatives
GB2116545B (en) 23-0-substituted carbamoyl-23-demycinosyldesmycosin derivatives
GB2124216B (en) Eburnane derivatives
GB2124215B (en) Eburnane-oxime derivatives
GB2116176B (en) 3-azetidinylethyl-1-phenyl-2-imidazolidinone derivatives

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)